125 related articles for article (PubMed ID: 38273703)
1. Recurrent non-rheumatic streptococcal myocarditis: 18F-FDG PET/CMR findings.
Baltzinger P; El Ghannudi S; Germaini M; Von Hunolstein JJ; Zeyons F; Imperiale A
QJM; 2024 Jun; 117(6):457-459. PubMed ID: 38273703
[No Abstract] [Full Text] [Related]
2. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.
Nensa F; Kloth J; Tezgah E; Poeppel TD; Heusch P; Goebel J; Nassenstein K; Schlosser T
J Nucl Cardiol; 2018 Jun; 25(3):785-794. PubMed ID: 27638745
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography in clinically suspected myocarditis - STREAM study design.
Ozierański K; Tymińska A; Kobylecka M; Caforio ALP; Šobić-Šaranović D; Ristić AD; Maksimović R; Seferović PM; Marcolongo R; Królicki L; Opolski G; Grabowski M
Int J Cardiol; 2021 Jun; 332():113-118. PubMed ID: 33657398
[TBL] [Abstract][Full Text] [Related]
4. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
[TBL] [Abstract][Full Text] [Related]
5. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.
Peretto G; Busnardo E; Ferro P; Palmisano A; Vignale D; Esposito A; De Luca G; Campochiaro C; Sartorelli S; De Gaspari M; Rizzo S; Dagna L; Basso C; Gianolli L; Della Bella P; Sala S
JACC Cardiovasc Imaging; 2022 Oct; 15(10):1771-1780. PubMed ID: 36202457
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
[TBL] [Abstract][Full Text] [Related]
7. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis.
Werner RA; Wakabayashi H; Bauer J; Schütz C; Zechmeister C; Hayakawa N; Javadi MS; Lapa C; Jahns R; Ergün S; Jahns V; Higuchi T
Eur Heart J Cardiovasc Imaging; 2019 Apr; 20(4):467-474. PubMed ID: 30102319
[TBL] [Abstract][Full Text] [Related]
9. The role of 18F fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in children with rheumatic carditis and chronic rheumatic heart disease.
Nagesh CM; Saxena A; Patel C; Karunanithi S; Nadig M; Malhotra A
Nucl Med Rev Cent East Eur; 2015; 18(1):25-8. PubMed ID: 25633513
[TBL] [Abstract][Full Text] [Related]
10. Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis.
Sperry BW; Oldan JD; Hsich EM; Reynolds JP; Tamarappoo BK
J Nucl Cardiol; 2015 Aug; 22(4):840-4. PubMed ID: 25968627
[TBL] [Abstract][Full Text] [Related]
11. Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
Abgral R; Dweck MR; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Padilla M; Miller M; Lala A; Sanz J; Narula J; Fuster V; Contreras J; Kovacic JC; Fayad ZA
JACC Cardiovasc Imaging; 2017 May; 10(5):594-597. PubMed ID: 27372018
[No Abstract] [Full Text] [Related]
12. Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?
Chen W; Jeudy J
Curr Cardiol Rep; 2019 Jun; 21(8):76. PubMed ID: 31243587
[TBL] [Abstract][Full Text] [Related]
13. Unmasking disseminated streptococcal infection: role of FDG PET/CT in diagnosis and assessing response to antibiotic treatment.
Suthar RR; Purandare N; Shukla V; Jain Y; Manikandan MV; Agrawal A; Shah S; Puranik A; Rangarajan V
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):962-963. PubMed ID: 36301323
[No Abstract] [Full Text] [Related]
14. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
Lee JW; Nam SB; Kim SJ
Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of fusion
Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
[TBL] [Abstract][Full Text] [Related]
16.
Ederhy S; Devos P; Pinna B; Funck-Brentano E; Abbar B; Fenioux C; Cohen AA; Moslehi J; Bretagne M; Allenbach Y; Kharroubi D; Salem JE
Arch Cardiovasc Dis; 2022 Feb; 115(2):114-116. PubMed ID: 35120869
[No Abstract] [Full Text] [Related]
17. Hybrid FDG-PET/MR or FDG-PET/CT to Detect Disease Activity in Patients With Persisting Arrhythmias After Myocarditis.
Palmisano A; Vignale D; Peretto G; Busnardo E; Calcagno C; Campochiaro C; De Luca G; Sala S; Ferro P; Basso C; Del Maschio A; De Cobelli F; Esposito A
JACC Cardiovasc Imaging; 2021 Jan; 14(1):288-292. PubMed ID: 32305473
[No Abstract] [Full Text] [Related]
18. 18F-FDG PET in detecting metastatic infectious disease.
Bleeker-Rovers CP; Vos FJ; Wanten GJ; van der Meer JW; Corstens FH; Kullberg BJ; Oyen WJ
J Nucl Med; 2005 Dec; 46(12):2014-9. PubMed ID: 16330565
[TBL] [Abstract][Full Text] [Related]
19. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
20. The Evaluation of Lupus Myocarditis with 13N-Ammonia and 18F-FDG PET.
Alchammas J; Al-Faham Z; Roumayah Y; Wong OC
J Nucl Med Technol; 2016 Sep; 44(3):210-1. PubMed ID: 26769599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
